US Patent 8293228 Variant form of urate oxidase and use thereof

Patent 8293228 was granted and assigned to Savient Pharmaceuticals, Inc. on October, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Savient Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82932280

Patent Inventor Names

Jacob Hartman0

Simona Mendelovitz0

Date of Patent

October 23, 2012

Patent Application Number

134521510

Date Filed

April 20, 2012

Patent Citations Received

‌

US Patent 11781119 Variant forms of urate oxidase and use thereof

‌

US Patent 12121566 Methods for treating gout

‌

US Patent 11982670 Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy

Patent Primary Examiner

‌

Nashaat Nashed

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8293228 Variant form of urate oxidase and use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API